Cardiac magnetic resonance or computed tomography: are we ready for a change of gold standard before transcatheter aortic valve replacement?

Danuta Sorysz,Marc Dweck
DOI: https://doi.org/10.1093/cvr/cvae069
IF: 13.081
2024-05-11
Cardiovascular Research
Abstract:The initial foray into percutaneous valve implantation was made in 2000, with a procedure on a pulmonary valve. Implementing this approach in the aortic valve, located on the left side and associated with high-pressure, posed substantial challenges. These included the risk of coronary artery outlet occlusion, amongst other issues. Nevertheless, a mere two years later, in 2002, Alain Cribrier performed the first transcatheter aortic valve implantation (TAVI). Over the subsequent decade, TAVI secured its place in clinical practice guidelines. 1,2 Initially, the procedure was approved for inoperable or extreme-surgical-risk patients. This scope was broadened to high-risk patients in 2012 and intermediate-risk patients in 2016. By 2021, 19 years after Cribrier's pioneering procedure, TAVI was approved for low-risk patients. 2
cardiac & cardiovascular systems
What problem does this paper attempt to address?